Bueno Muiño, C.; Martín, M.; del Monte-Millán, M.; García-Saénz, J.Á.; López-Tarruella, S.
HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping. Cancers 2022, 14, 512.
https://doi.org/10.3390/cancers14030512
AMA Style
Bueno Muiño C, Martín M, del Monte-Millán M, García-Saénz JÁ, López-Tarruella S.
HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping. Cancers. 2022; 14(3):512.
https://doi.org/10.3390/cancers14030512
Chicago/Turabian Style
Bueno Muiño, Coralia, Miguel Martín, María del Monte-Millán, José Ángel García-Saénz, and Sara López-Tarruella.
2022. "HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping" Cancers 14, no. 3: 512.
https://doi.org/10.3390/cancers14030512
APA Style
Bueno Muiño, C., Martín, M., del Monte-Millán, M., García-Saénz, J. Á., & López-Tarruella, S.
(2022). HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping. Cancers, 14(3), 512.
https://doi.org/10.3390/cancers14030512